Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.41 |
| ▸ | CHRNA5 | P30532 | 1/20 | 0.41 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.41 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | GAPDH | P04406 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18521255 | 1.00 | ALDH1A1 (0.48) | ALDH1A1KMT2ATDP1SLC6A2SLC6A3 | |
| SCHEMBL13607677 | 1.00 | ALDH1A1 (0.48) | ALDH1A1KMT2ATDP1SLC6A2SLC6A3 | |
| SCHEMBL19326428 | 0.89 | ALDH1A1 (0.50) | ALDH1A1KMT2ATDP1SLC6A2SLC6A3 | |
| SCHEMBL21015462 | 0.89 | ALDH1A1 (0.50) | ALDH1A1KMT2ATDP1SLC6A2SLC6A3 | |
| SCHEMBL13171302 | 0.89 | ALDH1A1 (0.50) | ALDH1A1KMT2ATDP1SLC6A2SLC6A3 | |
| SCHEMBL10017441 | 0.87 | LGALS9 (0.38) | ALDH1A1KMT2ATDP1SLC6A2SLC6A3 | |
| SCHEMBL10048538 | 0.87 | LGALS9 (0.46) | ALDH1A1KMT2ATDP1SLC6A2SLC6A3 | |
| SCHEMBL13607676 | 0.86 | ALDH1A1 (0.46) | ALDH1A1KMT2ATDP1SLC6A2SLC6A3 | |
| SCHEMBL6369092 | 0.86 | ALDH1A1 (0.46) | ALDH1A1KMT2ATDP1SLC6A2SLC6A3 | |
| SCHEMBL1030464 | 0.86 | ALDH1A1 (0.46) | ALDH1A1KMT2ATDP1SLC6A2SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7858761-B2 | 1-α-halo-2,2-difluoro-2-deoxy-D-ribofuranose derivatives and process for the preparation thereof | HANMI PHARM. CO., LTD (KR) | 2010-12-28 | — | — | US | disclosed |
| US-20070238865-A1 | intermediates in preparation of gemcitabine in large scale; reducing 1-oxoribose compound to obtain actol compound, reacting with halophosphate compound in presence of base to obtain a 1-phosphate furanose derivative, reacting with halide source, then crystallizing | HANMI PHARM CO., LTD (KR) | 2007-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070238865-A1 | intermediates in preparation of gemcitabine in large scale; reducing 1-oxoribose compound to obtain actol compound, reacting with halophosphate compound in presence of base to obtain a 1-phosphate furanose derivative, reacting with halide source, then crystallizing | DCTPP1, NUDT1, TYMP | ALDH1A1 914/4885KMT2A 3562/4885TDP1 373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.